Adlai Nortye to Participate in Investor Conferences

Friday, Nov 21, 2025 8:01 am ET1min read

Adlai Nortye, a clinical-stage biotech company, announced that its management team will participate in upcoming investor conferences. Members will give fireside chats and virtual presentations at the Evercore Healthcare Conference and Oppenheimer Annual Healthcare Life Sciences Conference. The company is focused on developing innovative cancer therapies, including next-generation immunotherapies and RAS-targeting therapies.

Adlai Nortye to Participate in Investor Conferences

Comments



Add a public comment...
No comments

No comments yet